Johnson & Johnson Aktie

Johnson & Johnson für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 853260 / ISIN: US4781601046

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
15.04.2025 12:27:14

Johnson & Johnson Q1 Profit Increases, Beats Estimates

(RTTNews) - Johnson & Johnson (JNJ) reported a profit for its first quarter that increased from the same period last year and beat the Street estimates.

The company's bottom line came in at $10.999 billion, or $4.54 per share. This compares with $3.255 billion, or $1.34 per share, last year.

Excluding items, Johnson & Johnson reported adjusted earnings of $6.706 billion or $2.77 per share for the period.

Analysts on average had expected the company to earn $2.58 per share. Analysts' estimates typically exclude special items.

The company's revenue for the period rose 2.4% to $21.893 billion from $21.383 billion last year.

Johnson & Johnson earnings at a glance (GAAP) :

-Earnings: $10.999 Bln. vs. $3.255 Bln. last year. -EPS: $4.54 vs. $1.34 last year. -Revenue: $21.893 Bln vs. $21.383 Bln last year.

-Guidance: Full year EPS guidance: $10.50 - $10.70 Full year revenue guidance: $91.0 - $91.8 Bln

Analysen zu Johnson & Johnsonmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Johnson & Johnson 150,66 0,27% Johnson & Johnson